We’re here to help you with your case.
As of September 2022, about 30,000 Roundup lawsuits are still active.
Many thousands more have been filed in state courts by those immediately affected or their loved ones.
Water contamination claims at Camp Lejeune is an important issue for veterans and their families. Many experienced health issues due to the exposure in the water, and it can be difficult for veterans and their families to receive the compensation and care they need. We can help you understand the types of illnesses associated with the water contamination, the timeline related to the claims, resources available, and contact us to learn how we can help you for free.
Under the law, all veterans must file their claim within 3 years of the time they are first notified about their possible illness related to the water contamination. It is important that if you’re affected by camp Lejeune water contamination to act quickly if you want to file a claim.
What If You Were Not in the Roundup Settlement? Contact us today to receive your FREE Consultation.
Why the Roundup Cases Settled and What the Settlement Means for the Future
Let’s talk for a second about the global Roundup settlement. First, why did Monsanto agree to a settlement? Bayer offered settlement amounts e cases because juries were loudly telling them that Monsanto Roundup weed killer is a carcinogen that can cause cancer.
Bayer stuck its chest out too long and probably trusted its outside lawyers too much. But, eventually, reason prevailed and a global settlement was reached. But our Roundup lawyers continue to get calls from victims every day. Because the Roundup weed killer cancer lawsuits are far from over.
We are on to Round Two which may, as we discuss below, yield higher Roundup settlement amounts.
The problem with this weed killer is glyphosate, the main ingredient of this pesticide. Many scientists believe glyphosate causes an increased risk for the development of certain forms of cancer, including non-Hodgkin’s lymphoma (NHL) and hairy cell leukemia. The World Health Organization (WHO) declared it a “probable human carcinogen” due to the ingredient glyphosate.
At first, the science behind this was unclear. Monsanto’s lawyers hoped judges would seize on some scientists’ belief that the long-term consequences of Roundup exposures are hard to quantify. The problem was that much of the conventional wisdom was science ghostwritten by Monsanto.
So many Roundup lawyers thought the Monsanto Roundup lawsuits might be a coin toss between Monsanto/Bayer and the victims. This was wrong. Dead wrong. Jurors awarded billions in the three cases that went to trial.
Latest Roundup Lawsuit Update
If you have come for the latest Bayer Roundup news, this page was revised with a new litigation and settlement Roundup lawsuit update on January 21, 2023.
January 21, 2023: The Griswold Roundup lawsuit will begin on Monday in St. Louis before Judge Michael Mullen in the 22nd Judicial Circuit of Missouri.
January 18, 2023: There are currently still 4,158 active cases pending in the Roundup class action MDL in the Northern District of California. Many of these lawsuits have been settled. The MDL is still pending because a formal resolution was never approved by the Court before Bayer shifted its strategy and began settling large blocks of cases. Only a small handful of the cases pending in the MDL are newly filed. There were 4,100 pending cases in the MDL in July 2022.
January 11, 2023: A new Roundup jury trial is set to begin later this month in St. Louis. The case, Griswold v. Monsanto, was originally set for trial on January 9, 2023, but a 2-week postponement at the last minute pushed the date back to January 23, 2023. The last Roundup trial in St. Louis ended in a defense verdict. Meanwhile, Bayer managed to avoid going to trial in 2 other Roundup cases by settling.
December 27, 2022: The 11th Circuit recently agreed to an en banc review of a decision by a 3-judge panel which rejected Bayer’s federal preemption argument in the case of Carson v. Monsanto Co, 11th U.S. Circuit Court of Appeals, No. 21-10994. If you recall, this is the utterly goofy appeal that Bayer paid the plaintiff to bring.
In an en banc review, all of the 11th Circuit Judges will reconsider the appeal and evaluate if the original ruling was correct. Bayer already appealed this issue to the U.S. Supreme Court, which declined to hear the appeal.
Bayer seems pretty amped up about news but it is hard to understand why. Bayer has played the post-settlement well by offering reasonable settlement payouts for viable cases and getting some much-needed wins by letting weaker cases go to trial.
This has given Bayer some momentum going into the next round of settlements. These victories have sapped some of the excitement Roundup lawyers had at the beginning of the year. (Roundup lawsuit advertising has dropped a good deal lately.) But the notion that the 11th Circuit ruling will be in their favor or that a positive ruling would be a game-changer seems wishful.
December 14, 2022: Pied v. Monsanto, which was set to be tried in the Circuit Court of the Third Circuit of Hawaii, has been settled.
December 12, 2022: The Roundup trial that was supposed to get underway in San Francisco last month never happened because it was settled at the last minute.
The case, Langford v. Monsanto Co., et al. (CGC-21-592238), was in the Superior Court of California for San Francisco County, with a trial set for November 11, 2022. A few days before trial, however, the case was removed from the Court’s calendar, with a notation in the docket entry indicating “Case settled October 7, 2022.”
The terms of the settlement are confidential, so we don’t know what the amount of the settlement was. This is an indication that Bayer is continuing to settle strong cases and only going to trial in weaker cases that it has a good chance of winning.
November 14, 2022: Yet another Roundup cancer trial in Missouri has ended with a defense verdict in favor of Monsanto. The latest trial featured plaintiff Stacey Moore and began on October 21, 2022, in St. Louis County Circuit Court. The jury found in favor of Monsanto on all counts. Ten more Roundup trials are scheduled to begin around the country over the next few months.
The verdict marks the sixth consecutive Monsanto victory after three huge defeats in the first three Roundup lawsuits. Did Bayer’s lawyers figure out a magic formula with jurors? That is one theory. The more plausible theory is that Bayer making fair settlement offers in good cases and letting the weaker Roundup lawsuits go to trial.
November 11, 2022 Update: Jury selection begins today in Langford v. Monsanto, the latest Roundup cancer case to go to trial. This trial will be in the Superior Court of California in San Francisco. The plaintiff, Michael Langford, was diagnosed with non-Hodgkin’s lymphoma in 2007 and was granted an expedited trial because of his rapidly failing health. This will be the first Roundup trial since the 3-plaintiff trial in St. Louis that Bayer won.
November 5, 2022 Update: The next Roundup trial starts on Monday in California. The plaintiff in this case was diagnosed with NHL in 2007. He has had 5 recurrences and has endured all of the sufferings that come with that. He used Roundup for 34 years.
November 1, 2022 Update: The scientific evidence regarding the dangers of Roundup just continues to accumulate. It seems like every month a new study comes out linking glyphosate exposure to a new health hazard. The latest study came from a research team in Brazil which found that prenatal exposure to Roundup can cause fetal liver damage and inflammation. The study was published in the most recent issue of the Journal of Toxicology and Applied Pharmacology.
October 19, 2022 Update: Another Roundup cancer case is set to go to trial in St. Louis County again. The case, Moore v. Monsanto, et al., is set for trial on October 21, 2022, and should last for 3 weeks. This is will be the second Roundup case to go before a jury in St. Louis in the last few months.
October 4, 2022 Update: A new study in a major medical journal found that exposure to glyphosate (the ingredient in Roundup) caused increased rates of thyroid cancer. The study was done by a research team from UCLA and looked at 29 different types of pesticides. It found that residential glyphosate exposure over 20 years increased the rate of thyroid cancer by 36%. Our lawyers are unaware of any thyroid cancer Roundup lawsuits and we not accepting these cases yet. But it is certainly something to keep an eye on to see if other studies replicate this finding.
October 2, 2022 Update: Trial dates coming up:
11/7/2022Langford v. Monsanto (California)11/29/2022Pied v. Monsanto (Hawaii)1/9/2023Griswold v. Monsanto (St. Louis)1/23/2023Freiwald v. Monsanto (California)September 20, 2022 Update: Bayer is now facing product liability lawsuits involving herbicide products other than Roundup. A federal court in Missouri recently denied a motion to dismiss claims against Bayer by a honeybee farm alleging damage caused when Bayer’s dicamba herbicide products vaporized and drifted onto adjacent lands. The case claims that the migrated dicamba killed bees and reduced honey output.
September 7, 2022 Update: Plaintiffs score a win in Texas as a federal court in Texas denied a motion for summary judgment filed by Bayer in a Roundup lawsuit heading for trial. But it was not an unexpected win. Bayer’s motion again pushed its federal preemption defense that was rejected by the 9th Circuit and which the Supreme Court declined to consider. We will continue to see more Roundup trials around the country that hopefully drive these claims toward a more global settlement.
September 2, 2022 Update: It is not fun reporting on the losses. We explain below why the recent Roundup losses are misleading. But they are still losses and we cannot run from that.
After a trial that lasted nearly a month and featured the claims of three plaintiffs (all in their 60s), a jury in St. Louis returned a defense verdict in favor of Bayer/Monsanto on all claims.
Back in 2018, the first handful of Roundup bellwether trials all resulted in massive verdicts for the plaintiffs, essentially forcing Bayer to waive the white flag and pursue a settlement strategy. Since then, however, Bayer has scored defense victories in a series of 5 state court jury trials in a row.
Again, and our lawyers think this cannot be underscored enough, this trend is somewhat misleading because, unlike the early bellwether trials, Bayer has been able to hand-pick many of the recent cases that have gone to trial. At least four of the last five defense verdicts have been in cases where there we fundamental holes that the classic Monsanto Roundup NHL lawsuit does not have.
August 25, 2022 Update: The St. Louis trial continues to slowly move forward. We are still in the plaintiffs’ case so a verdict is still a ways off.
Marty Cox and Gary Gentile, two of the three individual plaintiffs in the Alesi Roundup trial in St. Louis, recently took the stand to testify. Gentile was diagnosed with high-grade-B-cell lymphoma after using Roundup for years to kill weeds. Gentile’s wife also took the stand to testify about the emotional toll that her husband’s disease has had. On cross, Bayer’s lawyers pushed the narrative that none of Gentile’s doctors even actually told him that Roundup caused his disease. Of course, that is not their job. The other plaintiff, Cheryl Davis, will take the stand next. Plaintiffs are expected to close their case after that testimony.
August 15, 2022 Update: The opening days of the Alesi Roundup trial in St. Louis featured testimony from Dr. Charles Benbrook and William Sawyer, both expert witnesses for the Plaintiffs. Dr. Benbrook is a prominent agricultural economist who has written books and been an expert witness in all of the Roundup trials. Benbrook’s testimony lasted almost 2 full days. Next up on the stand was William Sawyer, the Plaintiffs’ toxicology expert. Sawyer has been a witness in previous Monsanto lawsuits that have gone to trial, including the Pilliod trial which ended in a verdict of nearly $2 billion.
August 10, 2022 Update: The results of a new study now indicate that glyphosate, the active ingredient in Roundup that has been linked to non-Hodgkin’s lymphoma, may also increase the risk of Parkinson’s disease and other neurologic disorders. The study found that glyphosate can pass through the blood-brain barrier, which is a hallmark of many chemicals that are known to cause neurologic disorders such as Parkinson’s. The study was published in this week’s edition of the Journal of Neuroinflammation. Our lawyers are not taking Roundup Parkinson’s lawsuits. But this is something to keep an eye on.
August 9, 2022 Update: Another new Roundup trial started last week in St. Louis in the case of Alesi, et al. v. Monsanto, et al. Despite objections by Bayer’s defense team, the entire trial is being webcast by Courtroom View Network. The case features three plaintiffs (all of whom are over the age of 60) who allege that they developed lymphoma from years of regularly using Roundup. This will be the first Roundup trial in St. Louis County Circuit Court, a notoriously plaintiff-friendly venue. Back in April, Bayer settled a large block of cases just to avoid going to trial in St. Louis County. Bayer reportedly still has billions set aside to settle current and future Roundup cases.
July 21, 2022 Update: Glyphosate is the active chemical ingredient in Roundup that has been linked to lymphoma and is now considered a human carcinogen. The CDC released the surprising results of a study that found that 8 out of 10 people in the U.S. have glyphosate in their urine. The study tested urine samples from a group of participants designed to represent the U.S. population and found that 80% of the samples had trace amounts of glyphosate. The CDC indicated concern over the study results and suggested that additional research was needed. (If they are looking for a shortcut, there are many studies Roundup juries have seen that show the link between Roundup and NHL.)
July 8, 2022 Update: The prospect of future Roundup liabilities continues to cast a shadow on Bayer in the eyes of investors. On June 21st, the Supreme Court formally declined to hear Bayer’s appeal that could have reversed the course of the Roundup litigation and ended any future liabilities. Since then, Bayer’s stock is down about 12% as investors are once again very concerned about how much the continuing litigation may end up costing the company. Even though glyphosate-based Roundup will be taken off the retail market at the end of this year, there could be thousands of former Roundup users who will be diagnosed with NHL and become Roundup plaintiffs over the next decade.
July 4, 2022 Update: A unanimous Ninth Circuit panel told the EPA to reconsider its conclusion that the weedkiller Roundup is free from “unreasonable risk to man or the environment.” The court agreed with environmental and food safety advocates that the EPA did not fully consider whether Roundup causes cancer. Importantly, the court pointed out that “most studies EPA examined indicated that human exposure to glyphosate is associated with an at least somewhat increased risk of developing NHL.” This does not jive with the EPA’s “not likely to cause cancer” conclusion.
Bayer’s momentum from a few wins in recent Roundup lawsuits is now dead. History is not on the side of glyphosate.
June 23, 2022 Update: Bayer gets its fourth straight win in a Monsanto lawsuit in Oregon. Bayer’s Roundup lawyers have made a lot of mistakes in this litigation. But this new “settle the hard Roundup cancer lawsuits and try the claims that are difficult for plaintiffs” is giving Bayer new, albeit artificial, momentum.
June 11, 2022 Update: Bad news. The jury found for Bayer in Shelton after 7 hours of deliberation yesterday. This is bad news. But, ultimately, it is important to keep in mind that Bayer is settling the cases it does not want to go to trial – like it did the last round of cases in St. Louis – and trying the cases that it should win. Even with that caveat, it is a tough loss for all plaintiffs with a pending Roundup lawsuit.June 4, 2022 Update: An administrative judge in Philadelphia ordered that 100 pending Monsanto lawsuits be consolidated into a class action lawsuit. Judge Lysette Shirdon-Harris’ order effectively creates a mini Roundup class action lawsuit in Pennsylvania.
How can Bayer/Monsanto be sued in state court? The Roundup lawsuit being filed in Pennsylvania named Philadelphia-based chemical maker Nouryon as a defendant. This is a very favorable jurisdiction for defendants, so much so that plaintiffs outside of Pennsylvania are joining this Roundup class action lawsuit.
June 2, 2022 Update: Former Monsanto CEO Hugh Grant’s much-awaited testimony was given in Shelton last week. The most important concession from Mr. Grant was that Monsanto never bothered to do their own tests to see if there was a connection between Roundup and NHL or CLL.
May 11, 2022 Update: Big Bayer Monsanto news yesterday. The Biden administration asked the U.S. Supreme Court to reject Bayer’s appeal that argued every Roundup lawsuit because it is preempted by the Federal Insecticide, Fungicide, and Rodenticide Act. Solicitor General Elizabeth Prelogar wrote that the “EPA’s approval of labeling that does not warn about particular chronic risks does not by itself preempt a state-law requirement to provide such warnings.” The Supreme Court had asked the administration if it believed the Supreme Court should hear Bayer’s appeal. This is a huge win for plaintiffs.
May 4, 2022 Update: If Shelton v. Monsanto does go to trial, former Monsanto CEO Hugh Grant will be required to testify, over Bayer’s objections. This would be the first Monsanto lawsuit to go to trial outside of California.
April 29, 2022 Update: The Round MDL judge indicated that he is prepared to approve a proposed settlement of the Roundup consumer class action cases alleging that Monsanto illegally marketed Roundup without providing cancer warning labels. (Our lawyers talk more about his lawsuit in our February 3, 2022 update below.)
The pending settlement will establish a $45 million fund to resolve these class actions. However, Judge Chhabria stated that he will not give final approval unless steps are taken to ensure that the settlement does not confuse plaintiffs who may still file a Roundup cancer lawsuit if they develop NHL in the future. The judge fears victims will think accepting a Roundup settlement check for the consumer lawsuits will mean you cannot bring a claim if you later are diagnosed with cancer as the result of exposure to this pesticide.
Hopefully, this is a precursor to Bayer offering reasonable settlement payouts to the remaining victims to resolve the remaining glyphosate lawsuits.
April 13, 2022 Update: Bayer does not appear to be willing to let another Roundup lawsuit go to trial if the plaintiff has a reasonable claim. Last week, Bayer agreed to a settlement to resolve a group of Roundup lawsuits. This settlement allowed the company to avoid a trial set to start this week in Kansas City. Many of the remaining Roundup claims are pending in state court in Missouri.
April 10, 2022 Update: Much of the energy in the Roundup class action lawsuit is focused on whether the U.S. Supreme Court will hear Bayer’s preemption appeal. The Supreme Court has asked the Biden administration to submit a brief with its position on whether the government believes every Roundup Monsanto lawsuit should be preempted by the Federal Insecticide, Fungicide, and Rodenticide Act. There is speculation that the Solicitor General will file a response in the late spring. The position the Biden administration will take is anyone’s guess. But it is hard to imagine a scenario where the Environmental Protection Agency – which reviews a pesticide every 15 years – will want to serve as police, judge, and jury on every lawsuit involving a pesticide.
March 23, 2022 Update: Bayer has appealed another Roundup verdict to the U.S. Supreme Court. Bayer filed a 43-page writ of certiorari to our high court regurgitating its preemption argument that has yet to gain traction with other courts. The argument is essentially that because the EPA has found Roundup safe, any Roundup lawsuit alleging Roundup causes cancer is preempted by the Federal Insecticide, Fungicide, and Rodenticide Act, the federal statute that regulates herbicides and their labels. This appeal is off the $2 billion Roundup verdict that was later reduced to $86.7 million.
March 7, 2022 Update: There are now 4,005 cases remaining in the Roundup MDL. Increasingly, Roundup lawyers are bringing Roundup lawsuits in state court. Our Roundup cancer lawyers believe- and Bayer confirmed on an earnings call – there are approximately 31,000 Roundup lawsuits that have still not been settled. Some portion of these remaining Roundup cancer lawsuits may be time-barred by the statute of limitations. But many others are very viable lawsuits. Our lawyers continue to get new Roundup cases every week.
Bayer has set aside billions for Roundup settlements in the weed killer lawsuits that have not been settled. Hopefully, Bayer will come back with larger settlement offers this year to resolve more of these remaining claims.
February 22, 2022 Update: Roundup lawyers are increasingly looking to press forward with claims in state court. Roundup lawsuits are increasingly being filed in state courts and plaintiffs’ attorneys have been asking Judge Vince Chhabria to remand more cases back to state court. Too many Roundup victims have been waiting too long to get a trial date. Hopefully, more Roundup cancer lawsuits in state court will bring more timely justice.
February 17, 2022 Update: It is satisfying that Bayer’s investors are blaming Bayer in a new class action lawsuit for deceiving investors on the NHL risk associated with Roundup. While Bayer knew that Roundup was even more dangerous than glyphosate, Bayer’s CEO said on a conference call with investors that “there is no difference” between glyphosate and the Roundup formulation. It is hard to get excited by the investor lawsuit that is not about Roundup causing cancer and killing people but instead is about Round causing cancer and killing people which costs the investors money. But the enemy of my enemy… This Roundup lawsuit could also take another crack at the pre-trial discovery of what Bayer knew about the harm caused by this weed killer.
February 3, 2022 Update: Bayer has reached a settlement on yet another Roundup class action lawsuit. Bayer agreed to a settlement amount between $23 million and $45 million to resolve a Roundup weed killer class action lawsuit that alleged that consumers have paid too much for Roundup because Bayer/Monsanto did not inform consumers of the cancer risk associated with this weed killer.
Why does this settlement matter? The payout is not large. But it is another sign that Bayer may be getting closer to throwing in the towel in the Roundup litigation and might be more amenable to a global settlement to resolve the remaining cancer lawsuits against it.
December 28, 2021 Update: Bayer stock has been falling in the past few years and the purchase of Monsanto. The liability in the Roundup lawsuits that led to an $11 billion settlement is the primary cause. In Germany, where class action lawsuits are rare, there is a new $1.1 billion lawsuit against Bayer making the same core complaint as Roundup victims: Bayer deceived plaintiffs about whether Roundup causes non-Hodgkin’s lymphoma. This time, instead of NHL cancer victims, it is investors making the same argument. Had Bayer been honest about NHL and Roundup, plaintiffs claim they would have changed their investment decisions because of the cost the Roundup lawsuits have taken on the company. More than 250 investors have joined this new class action lawsuit against Bayer. This may be a necessary push to get Bayer to offer more reasonable Roundup settlement amounts in Phase 2 of this litigation.
December 18, 2021 Update: On Monday, the Supreme Court asked the Biden administration to “file a brief in this case expressing the views of the United States” in Bayer/Monsanto’s appeal of a $25 million verdict in the Roundup lawsuits. Monsanto took this news with glee, announcing it was halting further Roundup settlements pending the outcome of the appeal.
Bayer’s long-shot hope for avoiding future liability on Roundup cases has been this appeal to the U.S. Supreme Court in the Hardeman case. Hardeman was awarded $25 million in damages after one of the first Roundup trials. Bayer has subsequently appealed that verdict arguing that the Roundup lawsuits should be legally precluded because federal regulators approved the product label on Roundup which did not contain a cancer warning.
The Ninth Circuit Court of Appeals flatly rejected Bayer’s federal preemption argument and upheld the Hardeman verdict. Now Bayer has filed a Cert. A petition asking the U.S. Supreme Court to hear the case and overrule the decision of the Ninth Circuit. The SCOTUS appeal is considered a legal long-shot, the odds of the court even agreeing to hear the case is small. Why do our Roundup lawyers believe the chance of Supreme Court review is small? The key Supreme Court case on whether the Federal Insecticide, Fungicide, and Rodenticide Act preempts state law failure-to-warn claims found that it does not.
So are we worried about a Supreme Court Roundup ruling? Lawyers worry about everything. But, again, the odds of the Supreme Court overturning this Roundup verdict is low.
December 13, 2021 Update: The 4th jury trial in the ongoing Roundup litigation ended last week in a defense verdict for Bayer. The trial in Donnetta Stephens v. Monsanto was tried via Zoom because of California’s continuing COVID restrictions. The result was a disjointed and awkward proceeding that took nearly 3 months to complete. The trial was continuously plagued by technical difficulties. In the end, the jury found that the plaintiff’s use of Roundup was not the cause of her cancer.
Our Roundup lawyers are admittedly disheartened by the first loss in a prototypical Roundup case where the victim claims her non-Hodgkin’s lymphoma was caused by the pesticide. For sure, Bayer’s lawyers will now think they now cracked the secret sauce to defend a Roundup NHL lawsuit. But this online trial is such a one-off it is hard to give much precedential value to this lawsuit in terms of calculating future settlement amounts for a Roundup lawsuit.
December 5, 2021 Update: Bayer’s appeal of a $25 million Roundup payout is now on the United States Supreme Court’s December 10, 2021 conference calendar. Bayer contends that the FIFRA preempts state law failure to warn of the risk of cancer claims. (The prediction here is that the Supreme Court refuses to hear the case.)
November 28, 2021 Update: The California Supreme Court court rejected last week Bayer’s attempt to reverse an $86.2 million compensation award to a couple who both developed cancer after using Roundup. This is a big win that keeps the moment flowing with victims as the Roundup litigation continues to move into the post-settlement phase with new Roundup lawsuits being filed every week.
November 26, 2021 Update: Regulators, at least those in Europe, are starting to catch on to the idea that the literature supporting the safety of pesticides like Roundup is mostly garbage. Only two of eleven studies given to EU regulators were found to be reliable.
November 18, 2021 Update: Bayer won its first trial in Roundup in a case in California state court alleging that a child’s rare form of non-Hodgkin’s lymphoma was caused by his mother’s use of Roundup in her garden. The jury found that the child’s exposure to Roundup was not a substantial cause of his cancer. This is the 4th Roundup trial and the first time Bayer has won a defense verdict. (2022 Update: it is worth mentioning that even after Bayer won this case at trial, it paid a confidential settlement amount to the victim. Ironically, Bayer is willing to pay a settlement to secure its win.)
Does this change the expected Roundup settlement amounts for the 25,000 who opted out of the $10 billion Roundup settlement or newly filed Monsanto weed killer lawsuits? No. The child in this case tragically developed Burkitt’s lymphoma, a rare form of non-Hodgkin’s lymphoma. A tragic case but it was a stretch to argue that the mother’s Roundup exposure was passed to the child.
Bayer is under attack from all sides. Last week, a federal judge in California gave the green light for a class action lawsuit against Bayer filed by pension funds that sued Bayer for failing to understand the litigation risks when it purchased Monsanto. Specifically, the lawsuit claims that Bayer lied about investigating the litigation risk associated with Roundup and simply “accepted at face value Monsanto’s characterization of its litigation risk.”
More details about the Stevens Roundup trial
